Skip to main content
Equibles

PNXP · PINEAPPLE EXPRESS CANNABIS Co

Track PNXP — free

Use PNXP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PNXP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 0.00 (-33.33%) At close · Oct 23
Rebalance outlook locked
Going-concern doubt — flagged Dec 19, 2025

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.”
View the 10-Q filed Dec 19, 2025
Market Cap
$46,857
Shares
42.60M
Volume · Oct 23 175K Avg daily vol (3M) 3.39M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.00 Day$0.00–0.00 52W close$0.00–0.01 Avg vol 30d3.6M Short int9K · 0.0% float · 1.0d Short vol26% DataApr 2023–Oct 2026 Filing10-Q · Dec 19

Up next

Latest filing: 10-Q
filed Dec 19, 2025

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$652,757
Trailing 12 months
Revenue growth YoY
-100.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$0
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-2.5%
Year over year · fewer shares
Price change (1Y)
-74.2%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▼71.7% $735 −$3,769 '23 Q3 · $1,964 −$3,616 '25 Q1 · $9,872 $4,292 '25 Q2 · $4,332 −$1,248 '25 Q3 · $0 −$30,581 '25 Q4* ▼100% $0 −$659,293 '26 Q1 ▼100% $0 $16,658 '26 Q2 LATEST ▼100% $0 $20,459 '26 Q3

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 19.5 · elevated Equity put/call 0.67
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −64%
below
Price vs 50-day avg −20%
below
RSI (14) 43
neutral
MACD trend Negative
52-week position 4%
near low
Momentum
relative strength
Very Weak
1-month return 0%
trailing
6-month return −58%
trailing
YTD return −87%
this year
Relative strength −64%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.02% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 17
low risk · 0–100
Fundamentals
Fair
Gross margin 33%
Balance sheet $0
net cash
Quant / Vol
risk profile
Very High
Volatility 431%
annualized · 1-yr
Max drawdown −94%
past year
ATR 50.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−64% Bearish
Price vs 50-day avg
−20% Bearish
RSI (14)
43 Neutral
MACD trend
Negative Bearish
52-week position
4% Bearish
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.02% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 4% Range high $0
vs 200-day avg -64% vs 50-day avg -20%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PNXP
PINEAPPLE EXPRESS CANNABIS Co
this stock
$46,857 -86.7% -30.5% — 0.0%
TAK
Takeda Pharmaceutical Co Ltd
 $64.66B +29.8% — — 0.1%
GALDY
Galderma Group AG
 $53.98B +11.7% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $45.92B +26.3% +4.3% 64.6 2.6%
HLN
Haleon plc
 $45.16B +1.6% — — 0.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest
Shares short
9.1K
Days to cover
1.0d
Change
0 sh
View
Short Volume
Short vol %
26%
As of
Oct 23, 2026
Short Total
View
Fails to Deliver
FTD shares
294.9K
Value
$0
As of
Apr 30, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$16.2K
Net income (FY)
$-31.2K
EPS diluted
$0.01
View
Filings
SEC Filings
Latest
8-K
Filed
May 5, 2026
This year
1
View
Exempt Offerings
Offering
$2.0M
Filed
Mar 23, 2023
View

Performance

5D 20D 120D MTD YTD
PNXP -27.3% +0.0% -57.9% +14.3% -86.7%
SPY -0.4% -1.5% +5.8% -0.4% +11.5%
vs SPY -26.8% +1.5% -63.7% +14.6% -98.1%
Key facts CIK 1710495 CUSIP 60251H102 Visit website